Alyra Therapeutics
Alyra is focused on the discovery and development of small molecule drugs for the treatment of cancer and rare disease. Our lead program ALY101 blocks CDC42 GTPase signaling with the potential to treat multiple solid tumors and rare diseases such as Ewing sarcoma and neurofibromatosis type 2.
** Currently Fundraising **
